Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/27/19 → 1/17/25 |
Funding
- Bristol Myers Squibb Company: $251,282.00
MCC-18-LUN-107-CLO: Phase II Study of Combination Rucaparib with Nivolumab in Platinum Sensitive Small Cell Lung Carcinoma Patients as Maintenance After Induction Therapy with Platinum Doublet
- Hao, Zhonglin (PI)
- Chauhan, Aman (Former PI)